Barnaby Page || 14th December 2016 || News analysis || Companies | Health and science | Marketing and Retailing | Regulation and Legislation | Geographies: Europe North America Norway Sweden United States
Swedish Match has at last obtained some answers from the U.S. Food and Drug Administration (FDA) on its attempt to have snus products classified as modified risk – and they mix outright rejections with some very mild encouragement.
Are you already a subscriber? login here Enjoy free subscription access Get access to premium content that is normally only available for subscribers. For the duration of a week, you can read our news analysis, identify market trends and understand upcoming changes in the industry, which will enable you to get ahead of your competitors. Benefits of subscription plans: Stay informed of any legal and market change in the sector that impacts your organization Maximise resources by getting market and legal data analysis daily in one place Make smart decisions by understanding how the regulatory and market landscape evolves Anticipate risks in your decisions by monitoring regulatory changes that impact your organization